Enhanced bimatoprost ophthalmic solution

CAFC
  • US 8,338,479 B2
  • Filed: 01/09/2009
  • Issued: 12/25/2012
  • Est. Priority Date: 03/16/2005
  • Status: Active Grant
First Claim
Patent Images

1. A composition for the treatment of elevated intraocular pressure comprising about 0.01% w/v bimatoprost and about 200 ppm benzalkonium chloride, at least one buffer and having a pH of about 7.3 wherein said composition is an aqueous liquid which is formulated for ophthalmic administration.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×